Copyright © 2021 Advocate Law Group P.C. ("Advocate")

All Rights Reserved

Here, let visitors know what will happen when they complete your form.

DO YOU QUALIFY?

Free Xeljanz Case Review

Begin here ...

Please provide me with a free, no obligation case review, and treat my information confidentially within Advocate Law Group P.C. and its Network. 

I accept Advocate's Privacy Policy & Terms of Use.

We’ll do all the work, saving you time, travel, and paperwork, and get you the money you deserve as quickly as possible.

Stress Free

Xeljanz, an Arthritis and Colitis Medicine, Linked to Cancer, Heart Problems, Blood Clots 

Advocate Law Group Network Attorneys Currently Reviewing Xeljanz Lawsuits. To request a free, no-obligation case review for yourself or a loved one, call or fill out the Form today.

You, and the 

Advocate Law Group Network

Together We Win!TM

Call 24/7 for 

Free Case Evaluation 

888.487.5342

Hundreds of Millions of Dollars

Won by the attorneys in the Advocate Law Group Network for thousands of clients nationwide. 

Top-Rated Nationwide Network

The power and strength of a top-rated nationwide network. And while we fight hard to win, we treat you, our clients, with the compassion and respect you deserve.


Xeljanz, an Arthritis and Colitis Medicine, Linked to Cancer, 

Heart Problems, Blood Clots 

Advocate Law Attorneys Currently Reviewing Xeljanz Lawsuits

            Xeljanz, a prescription drug produced by Pfizer, first reached the market in 2012. Initially approved to treat Rheumatoid Arthritis (RA), Xeljanz later gained approval to treat Psoriatic Arthritis in 2017 and Ulcerative Colitis in 2018. Following its release,  the drug has become incredibly popular, grossing over $1.5 billion for Pfizer in 2018 alone.

                Following an FDA-required clinical trial that showed Xeljanz users had a higher risk of blood clots and death, the agency added a black box warning (its most serious warning) to Xeljanz to warn of these risks in 2019. In February of 2021, the FDA issued another safety communication after studies revealed Xeljanz’s link to cancer and serious heart-related injuries. Unlike past warnings that only applied to the 10mg dose, this new warning applies to both the 5mg and 10mg doses.

               Xeljanz (chemically known as tofacitinib citrate) is a Janus Kinase (JAK) inhibitor, meaning it works by disrupting cell signals across the JAK pathways and reducing enzymes that can cause inflammatory reactions throughout the body. However, due to the way it functions, Xeljanz suppresses the immune system, putting patients at serious risk for infections and other harmful health effects.

            If you have been diagnosed with cancer, blood clots, and/or heart problems after taking Xeljanz, you may be entitled to compensation for your suffering, medical costs, lost wages, and more.

    You or a loved one might qualify if:

You have been diagnosed with cancer, blood clots (including Pulmonary embolism, Pulmonary Thrombosis, Deep Vein Thrombosis, and Arterial Thrombosis), and/or heart-related injuries (including heart attacks and strokes)

You have a history of taking Xeljanz (also known as Tofacitinib Citrate)

                Pfizer ignored Xeljanz’s links to a plethora of deadly health conditions and marketed it to consumers for years, causing immeasurable harm. To hold them accountable, call us toll-free or complete the form for a free case review. Our legal team is here  to help and will quickly respond to all inquiries.

 

            

 










Have a Question? Call Us Now!

888-ITS-LEGAL

(888-487-5342)